{
  "report_rows": [
    {
      "kpi": "Organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~3.4% vs. cons 3.0%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted gross-margin expansion",
      "prediction": "BEAT",
      "answer": "pred ~60 bps vs. cons 50 bps",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.89 vs. cons $0.88",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 organic sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.5% vs. cons 3.5% (FY26)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY26 adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.76 vs. cons $3.76 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted gross-margin expansion",
      "prediction": "UNCHANGED",
      "answer": "guide ~100 bps vs. cons 100 bps (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1,
  "day5_path": "STABILIZE",
  "day5_rationale": "A modest ~3.4% organic-sales result and ~$0.89 EPS support a positive initial reaction, but an unchanged FY26 EPS midpoint of ~$3.76 versus consensus ~$3.76 leaves limited out-period estimate upside; revisions should remain broadly flat after the beat.",
  "day5_confidence": "MEDIUM"
}